Angela A Abboud, PA
Physician Assistant · Santa Rosa
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Redwood Fam Dermatology Medical Associates - A Medical Corporation · 18 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Angela A Abboud’s office at (707) 545-4537 to ask if they take your plan before you enroll.
Original Medicare doctor bills
$112,795
Medicare paid this office $112,795 for 566 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 317 | $18,558 | $50 |
| Destruction of precancer skin growth, 15 or more growths | 142 | $18,380 | $107 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 24 | $11,237 | None |
| Return visit (30+ min) | 108 | $9,819 | $75 |
| Biopsy of related skin growth, first growth | 152 | $9,482 | $59 |
See all 16 services
| Short return visit (20+ min) | 317 | $18,558 | $50 |
| Destruction of precancer skin growth, 15 or more growths | 142 | $18,380 | $107 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 24 | $11,237 | None |
| Return visit (30+ min) | 108 | $9,819 | $75 |
| Biopsy of related skin growth, first growth | 152 | $9,482 | $59 |
| Destruction of precancer skin growth, 1 growth | 189 | $7,555 | $36 |
| Destruction of skin growth, 1-14 growths | 86 | $6,793 | $72 |
| Destruction of precancer skin growth, 2-14 growths | 140 | $3,581 | $5 |
| Application of light to destroy precancer skin growth | 24 | $2,743 | $78 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 12 | $2,668 | $222 |
| New patient visit (30+ min) | 35 | $2,144 | $61 |
| Biopsy of related skin growth, each additional growth | 40 | $1,881 | $35 |
| New patient visit (45+ min) | 14 | $1,508 | $108 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 12 | $1,302 | $100 |
| Short return visit | 32 | $1,110 | $34 |
| New patient visit (15+ min) | 22 | $568 | $26 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 58 | More than 88% of doctors who do this |
| Removal of skin lesions | 1148 | More than 94% of doctors who do this |
| Removal or shaving of skin growth | 16 | More than 69% of doctors who do this |
| Skin biopsy | 364 | More than 93% of doctors who do this |
Who their Medicare patients are
566 Original Medicare patients in 2024. Average age 75 · Under 65 4% · 85 and older 11% · Women 56% · Also on Medicaid 18% · Health risk score 0.96. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 58% · Coronary heart disease 22% · Diabetes 16% · Atrial fibrillation 16% · Chronic kidney disease 14% · Depression 14% · Cancer 12% · COPD 12% · Heart failure 9% · Stroke 5% · Dementia 3%.
The office billed $345,330, Medicare allowed $170,455 and paid $112,795; for 2,467 services of 46 kinds; $11,240 of it was for drugs given in the office and $101,555 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 566 | 2,467 | 75 | 0.96 | $345,330 | $112,795 |
| 2023 | 793 | 4,443 | 74 | 0.93 | $611,210 | $197,909 |
| 2022 | 364 | 1,489 | 73 | 1.02 | $214,511 | $79,242 |
| 2020 | 354 | 1,346 | 75 | 1.21 | $186,687 | $52,241 |
| 2019 | 665 | 3,664 | 74 | 1.16 | $471,080 | $150,656 |
| 2018 | 407 | 2,210 | 73 | 1.21 | $281,895 | $91,901 |
| 2017 | 290 | 1,460 | 72 | 1.11 | $139,789 | $43,275 |
| 2016 | 227 | 825 | 71 | 1.06 | $103,396 | $35,471 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 21 services
| Short return visit (20+ min) | 440 | $32,602 | $54 |
| Destruction of precancer skin growth, 15 or more growths | 195 | $32,016 | $116 |
| Biopsy of related skin growth, first growth | 277 | $19,918 | $63 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 25 | $12,792 | None |
| Destruction of precancer skin growth, 1 growth | 300 | $12,323 | $34 |
| Destruction of skin growth, 1-14 growths | 122 | $11,270 | $78 |
| Return visit (30+ min) | 115 | $10,876 | $76 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 41 | $9,739 | $226 |
| Destruction of precancer skin growth, 2-14 growths | 235 | $6,928 | $5 |
| New patient visit (30+ min) | 103 | $5,998 | $58 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 44 | $5,158 | $103 |
| Biopsy of related skin growth, each additional growth | 80 | $4,537 | $37 |
| Application of light to destroy precancer skin growth | 25 | $4,135 | $106 |
| Short return visit | 64 | $2,570 | $36 |
| New patient visit (45+ min) | 29 | $2,151 | $74 |
| New patient visit (15+ min) | 38 | $1,231 | $32 |
| Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 15 | $1,210 | $81 |
| Punch biopsy, first skin growth | 12 | $1,179 | $84 |
| Biopsy of ear | 17 | $1,052 | $55 |
| Injection into skin growth, 1-7 growths | 12 | $350 | $27 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 12 | $9 | None |
2022: 13 services
| Destruction of precancer skin growth, 15 or more growths | 91 | $11,966 | $127 |
| Short return visit (20+ min) | 176 | $11,381 | $64 |
| Biopsy of related skin growth, first growth | 117 | $8,563 | $73 |
| Return visit (30+ min) | 52 | $4,980 | $91 |
| Destruction of precancer skin growth, 1 growth | 111 | $4,430 | $39 |
| Destruction of skin growth, 1-14 growths | 45 | $3,856 | $84 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 15 | $3,556 | $237 |
| New patient visit (30+ min) | 37 | $2,827 | $76 |
| Destruction of precancer skin growth, 2-14 growths | 78 | $2,129 | $5 |
| Biopsy of related skin growth, each additional growth | 34 | $1,784 | $40 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 11 | $1,231 | $112 |
| Short return visit | 22 | $937 | $41 |
| New patient visit (15+ min) | 18 | $822 | $46 |
2020: 13 services
| Biopsy of related skin growth, first growth | 105 | $6,957 | $63 |
| Destruction of precancer skin growth, 15 or more growths | 58 | $5,859 | $95 |
| Short return visit (20+ min) | 142 | $5,733 | $37 |
| Return visit (30+ min) | 83 | $5,458 | $59 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 12 | $4,459 | None |
| Destruction of precancer skin growth, 1 growth | 100 | $3,383 | $31 |
| Destruction of skin growth, 1-14 growths | 35 | $3,203 | $70 |
| Biopsy of related skin growth, each additional growth | 38 | $2,380 | $39 |
| Destruction of precancer skin growth, 2-14 growths | 73 | $2,093 | $4 |
| New patient visit (30+ min) | 24 | $1,045 | $44 |
| Application of light to destroy precancer skin growth | 12 | $916 | $70 |
| New patient visit (15+ min) | 39 | $908 | $23 |
| Short return visit | 14 | $288 | $21 |
2019: 22 services
| Short return visit (20+ min) | 329 | $20,984 | $49 |
| Biopsy of related skin growth, first growth | 248 | $19,220 | $66 |
| Return visit (30+ min) | 130 | $12,279 | $71 |
| Destruction of precancer skin growth, 15 or more growths | 76 | $9,943 | $108 |
| Destruction of skin growth, 1-14 growths | 78 | $9,589 | $77 |
| Destruction of precancer skin growth, 1 growth | 184 | $8,361 | $35 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 28 | $6,386 | $220 |
| Biopsy of related skin growth, each additional growth | 81 | $5,820 | $39 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 13 | $5,565 | None |
| Destruction of precancer skin growth, 2-14 growths | 137 | $4,241 | $4 |
| New patient visit (15+ min) | 93 | $4,046 | $44 |
| New patient visit (30+ min) | 63 | $3,935 | $62 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 24 | $2,989 | $111 |
| Short return visit | 59 | $1,962 | $31 |
| Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 18 | $1,857 | $88 |
| Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | 15 | $1,648 | $110 |
| Punch biopsy, first skin growth | 17 | $1,562 | $92 |
| Application of light to destroy precancer skin growth | 13 | $1,423 | $84 |
| Biopsy of ear | 17 | $830 | $44 |
| Injection into skin growth, 1-7 growths | 14 | $435 | $27 |
| New patient visit (10+ min) | 13 | $364 | $28 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 14 | $18 | None |
2018: 16 services
| Short return visit (20+ min) | 204 | $14,131 | $47 |
| Biopsy of single growth of skin and/or tissue | 152 | $13,177 | $71 |
| Destruction of precancer skin growth, 1 growth | 128 | $5,591 | $35 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 24 | $5,591 | $215 |
| Destruction of skin growth, 1-14 growths | 33 | $4,705 | $78 |
| Return visit (30+ min) | 60 | $4,678 | $71 |
| Destruction of precancer skin growth, 15 or more growths | 32 | $4,045 | $101 |
| New patient visit (15+ min) | 93 | $3,823 | $41 |
| Biopsy of each additional growth of skin and/or tissue | 67 | $2,714 | $23 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 16 | $1,865 | $98 |
| New patient visit (30+ min) | 27 | $1,707 | $63 |
| Destruction of precancer skin growth, 2-14 growths | 83 | $1,648 | $4 |
| Short return visit | 45 | $1,413 | $28 |
| Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 11 | $994 | $90 |
| Injection into skin growth, 1-7 growths | 19 | $975 | $38 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 19 | $37 | None |
2017: 13 services
| Biopsy of single growth of skin and/or tissue | 86 | $6,807 | $69 |
| Short return visit (20+ min) | 96 | $5,743 | $50 |
| Destruction of precancer skin growth, 15 or more growths | 28 | $3,329 | $101 |
| New patient visit (30+ min) | 42 | $2,875 | $68 |
| Destruction of precancer skin growth, 1 growth | 72 | $2,812 | $34 |
| Destruction of skin growth, 1-14 growths | 24 | $2,325 | $77 |
| Return visit (30+ min) | 28 | $1,934 | $67 |
| New patient visit (15+ min) | 40 | $1,828 | $46 |
| Short return visit | 35 | $1,143 | $29 |
| Destruction of precancer skin growth, 2-14 growths | 47 | $1,067 | $4 |
| Biopsy of each additional growth of skin and/or tissue | 31 | $922 | $22 |
| New patient visit (10+ min) | 17 | $497 | $29 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 16 | $48 | None |
2016: 9 services
| Replacement of knee joint, both sides of knee | 64 | $10,354 | $162 |
| New patient visit (30+ min) | 41 | $3,360 | $82 |
| Replacement of knee joint on side of knee | 22 | $3,050 | $139 |
| Replacement of thigh bone and hip joint with prosthesis | 14 | $2,266 | $162 |
| Short return visit (20+ min) | 37 | $2,170 | $52 |
| Aspiration and/or injection of fluid from large joint | 16 | $1,240 | $52 |
| Return visit (30+ min) | 14 | $1,157 | $83 |
| X-ray of wrist, minimum of 3 views | 11 | $465 | $29 |
| X-ray of hand, minimum of 3 views | 11 | $301 | $25 |
Medicaid work
$5,915 in 2024
Medicaid paid $5,915 for 125 billed services this clinician did in 2024, up to 22 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 76 | $4,443 |
| Short return visit (20+ min) | 49 | $1,471 |
| 2024 | 125 | 2 | 22 | $5,915 |
| 2023 | 55 | 2 | 18 | $636 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 43 | $332 |
| Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); single lesion | 12 | $304 |
Drugs they prescribed that Part D paid
$489,386
Pharmacies billed $489,386 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 390) in 2024. At or below the middle of the specialty; the typical physician assistant clinician is at 1%.
338 generic and 52 brand-name prescriptions · $489,386 in drug cost · 23 antibiotic prescriptions to 15 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Skyrizi | 15 | $299,697 | $19,980 |
| Fluocinonide | 34 | $1,134 | $33 |
| Fluorouracil | 14 | $930 | $66 |
| Fluocinolone Acetonide | 16 | $768 | $48 |
| Ketoconazole | 56 | $755 | $13 |
See all 11 drugs
| Skyrizi | 15 | $299,697 | $19,980 |
| Fluocinonide | 34 | $1,134 | $33 |
| Fluorouracil | 14 | $930 | $66 |
| Fluocinolone Acetonide | 16 | $768 | $48 |
| Ketoconazole | 56 | $755 | $13 |
| Metronidazole | 11 | $666 | $61 |
| Ciclopirox | 18 | $589 | $33 |
| Triamcinolone Acetonide | 83 | $557 | $7 |
| Doxycycline Hyclate | 12 | $306 | $26 |
| Hydrocortisone | 24 | $96 | $4 |
| Mupirocin | 12 | $39 | $3 |
Year by year
| 2024 | 390 | 180 | 0% (0) | 13% | $489,386 |
| 2023 | 445 | 223 | 0% (0) | 12% | $451,347 |
| 2022 | 536 | 241 | None | 15% | $440,215 |
| 2021 | 426 | 195 | None | 11% | $210,032 |
| 2020 | 294 | 156 | 0% (0) | 17% | $126,285 |
| 2019 | 487 | 224 | None | 16% | $217,278 |
| 2018 | 355 | 178 | None | 5% | $29,673 |
| 2017 | 136 | 73 | 10% (14) | None | $5,489 |
| 2016 | 157 | 86 | 59% (92) | 7% | $4,197 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Cosentyx Sensoready (2 Pens) | 13 | $99,924 | $7,686 |
| Dupixent | 11 | $46,040 | $4,185 |
| Metronidazole | 16 | $2,220 | $139 |
| Fluocinonide | 27 | $1,604 | $59 |
| Fluorouracil | 16 | $1,462 | $91 |
| Fluocinolone Acetonide | 17 | $1,403 | $83 |
| Triamcinolone Acetonide | 122 | $956 | $8 |
| Ciclopirox | 13 | $804 | $62 |
| Ketoconazole | 40 | $703 | $18 |
| Doxycycline Hyclate | 17 | $596 | $35 |
| Cephalexin | 21 | $453 | $22 |
| Valacyclovir | 11 | $417 | $38 |
| Mupirocin | 13 | $236 | $18 |
| Hydrocortisone | 40 | $229 | $6 |
2022: 17 drugs
| Cosentyx Pen (2 Pens) | 19 | $131,210 | $6,906 |
| Otezla | 16 | $71,752 | $4,485 |
| Dupixent | 11 | $41,944 | $3,813 |
| Fluocinonide | 48 | $2,596 | $54 |
| Betamethasone Dipropionate | 19 | $1,417 | $75 |
| Fluorouracil | 14 | $1,400 | $100 |
| Fluocinolone Acetonide | 17 | $1,329 | $78 |
| Metronidazole | 17 | $1,145 | $67 |
| Ciclopirox | 16 | $847 | $53 |
| Ketoconazole | 35 | $674 | $19 |
| Triamcinolone Acetonide | 105 | $623 | $6 |
| Doxycycline Monohydrate | 14 | $551 | $39 |
| Valacyclovir | 12 | $505 | $42 |
| Hydrocortisone | 52 | $365 | $7 |
| Doxycycline Hyclate | 14 | $287 | $20 |
| Mupirocin | 20 | $222 | $11 |
| Cephalexin | 13 | $117 | $9 |
2021: 11 drugs
| Cosentyx Pen (2 Pens) | 15 | $106,584 | $7,106 |
| Fluocinonide | 45 | $3,397 | $75 |
| Fluocinolone Acetonide | 22 | $1,672 | $76 |
| Doxycycline Hyclate | 22 | $1,611 | $73 |
| Fluorouracil | 16 | $1,198 | $75 |
| Metronidazole | 16 | $1,129 | $71 |
| Ketoconazole | 34 | $893 | $26 |
| Ciclopirox | 18 | $641 | $36 |
| Triamcinolone Acetonide | 89 | $600 | $7 |
| Hydrocortisone | 24 | $149 | $6 |
| Cephalexin | 18 | $118 | $7 |
2020: 8 drugs
| Fluocinonide | 32 | $1,695 | $53 |
| Metronidazole | 15 | $1,659 | $111 |
| Fluorouracil | 12 | $1,415 | $118 |
| Doxycycline Hyclate | 20 | $757 | $38 |
| Triamcinolone Acetonide | 65 | $388 | $6 |
| Ketoconazole | 19 | $288 | $15 |
| Hydrocortisone | 31 | $122 | $4 |
| Cephalexin | 12 | $100 | $8 |
2019: 11 drugs
| Fluocinonide | 32 | $1,714 | $54 |
| Fluocinolone Acetonide | 19 | $1,553 | $82 |
| Clotrimazole | 23 | $1,206 | $52 |
| Doxycycline Hyclate | 19 | $859 | $45 |
| Betamethasone Dipropionate | 15 | $742 | $49 |
| Triamcinolone Acetonide | 84 | $565 | $7 |
| Ketoconazole | 24 | $481 | $20 |
| Cephalexin | 39 | $261 | $7 |
| Hydrocortisone | 47 | $250 | $5 |
| Ciclopirox | 11 | $237 | $22 |
| Mupirocin | 17 | $144 | $8 |
2018: 7 drugs
| Fluocinonide | 20 | $1,029 | $51 |
| Triamcinolone Acetonide | 91 | $548 | $6 |
| Doxycycline Hyclate | 18 | $403 | $22 |
| Mupirocin | 31 | $305 | $10 |
| Clotrimazole | 21 | $297 | $14 |
| Cephalexin | 53 | $294 | $6 |
| Hydrocortisone | 17 | $82 | $5 |
2017: 2 drugs
| Clotrimazole | 21 | $413 | $20 |
| Triamcinolone Acetonide | 19 | $118 | $6 |
2016: 6 drugs
| Hydrocodone-Acetaminophen | 29 | $642 | $22 |
| Oxycodone | 22 | $558 | $25 |
| Oxycodone-Acetaminophen | 16 | $411 | $26 |
| Ondansetron Odt | 11 | $176 | $16 |
| Tramadol | 21 | $144 | $7 |
| Amoxicillin | 13 | $28 | $2 |
Money from drug and device companies
$1,857 in 2025
| 2025 | 19 | 99 | None | $1,857 |
| 2024 | 19 | 67 | None | $1,379 |
| 2023 | 15 | 74 | None | $1,614 |
| 2022 | 10 | 54 | None | $1,026 |
| 2021 | 8 | 36 | None | $665 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Skyrizi | $279 | 17 payments
|
| Ucb | Bimzelx | $267 | 17 payments
|
| Pfizer | Cibinqo | $185 | 12 payments
|
| Regeneron Healthcare Solutions | Libtayo | $168 | 10 payments
|
| Lilly USA | Taltz | $151 | 7 payments
|
| LEO Pharma | Adbry | $136 | 8 payments
|
See all 99 published payments
| Abbvie | Meals · 2025-12-16 | Rinvoq | $22 |
| Ucb | Meals · 2025-12-13 | Bimzelx | $22 |
| Galderma Laboratories L.P. | Meals · 2025-12-09 | Nemluvio | $14 |
| Incyte | Meals · 2025-12-08 | Opzelura | $23 |
| LEO Pharma | Meals · 2025-12-03 | Anzupgo | $9 |
| LEO Pharma | Meals · 2025-12-03 | Anzupgo | $9 |
| Abbvie | Meals · 2025-11-26 | Skyrizi | $7 |
| Incyte | Meals · 2025-11-25 | Opzelura | $24 |
| Arcutis Biotherapeutics | Meals · 2025-11-20 | Zoryve | $22 |
| Regeneron Healthcare Solutions | Meals · 2025-11-14 | Libtayo | $10 |
| Regeneron Healthcare Solutions | Meals · 2025-11-14 | Libtayo | $0 |
| Sun Pharmaceutical Industries | Meals · 2025-11-14 | Ilumya | $22 |
| Janssen Biotech | Education · 2025-11-05 | Tremfya | $95 |
| Incyte | Meals · 2025-11-05 | Opzelura | $17 |
| Arcutis Biotherapeutics | Meals · 2025-11-04 | Zoryve | $14 |
| Regeneron Healthcare Solutions | Meals · 2025-10-31 | Libtayo | $10 |
| Regeneron Healthcare Solutions | Meals · 2025-10-29 | Libtayo | $2 |
| Botanix SB | Meals · 2025-10-28 | Sofdra | $25 |
| Incyte | Meals · 2025-10-21 | Opzelura | $23 |
| Ucb | Meals · 2025-10-17 | Bimzelx | $1 |
| Ucb | Meals · 2025-10-17 | Bimzelx | $22 |
| LEO Pharma | Meals · 2025-10-17 | Anzupgo | $8 |
| Abbvie | Meals · 2025-10-15 | Skyrizi | $23 |
| Lilly USA | Meals · 2025-10-14 | Taltz | $28 |
| LEO Pharma | Meals · 2025-10-10 | Adbry | $21 |
| Galderma Laboratories L.P. | Meals · 2025-10-02 | Nemluvio | $25 |
| Incyte | Meals · 2025-10-01 | Opzelura | $15 |
| Arcutis Biotherapeutics | Meals · 2025-09-30 | Zoryve | $17 |
| Ucb | Meals · 2025-09-25 | Bimzelx | $12 |
| Regeneron Healthcare Solutions | Meals · 2025-09-19 | Libtayo | $22 |
| Pfizer | Meals · 2025-09-19 | Cibinqo | $22 |
| Ucb | Meals · 2025-09-12 | Bimzelx | $12 |
| Amgen | Meals · 2025-09-02 | Otezla | $21 |
| Almirall | Meals · 2025-08-29 | Klisyri | $14 |
| Organon | Meals · 2025-08-28 | None | $21 |
| Galderma Laboratories L.P. | Meals · 2025-08-27 | Nemluvio | $25 |
| Ucb | Meals · 2025-08-15 | Bimzelx | $15 |
| Ucb | Meals · 2025-08-15 | Bimzelx | $15 |
| Novartis Pharmaceuticals | Meals · 2025-08-14 | Cosentyx | $32 |
| Lilly USA | Meals · 2025-08-12 | Taltz | $25 |
| Abbvie | Meals · 2025-08-05 | Rinvoq | $15 |
| Ucb | Meals · 2025-07-31 | Bimzelx | $14 |
| LEO Pharma | Meals · 2025-07-29 | Adbry | $20 |
| Abbvie | Meals · 2025-07-25 | Skyrizi | $7 |
| Regeneron Healthcare Solutions | Meals · 2025-07-22 | Libtayo | $11 |
| Organon | Meals · 2025-07-22 | Hadlima | $18 |
| Pfizer | Meals · 2025-07-18 | Cibinqo | $26 |
| Ucb | Meals · 2025-07-11 | Bimzelx | $25 |
| Pfizer | Meals · 2025-07-11 | Cibinqo | $19 |
| Pfizer | Meals · 2025-07-02 | Cibinqo | $11 |
| Ucb | Meals · 2025-06-27 | Bimzelx | $19 |
| Pfizer | Meals · 2025-06-24 | Cibinqo | $25 |
| Arcutis Biotherapeutics | Meals · 2025-06-24 | Zoryve | $23 |
| Regeneron Healthcare Solutions | Meals · 2025-06-18 | Dupixent | $29 |
| Abbvie | Meals · 2025-06-17 | Skyrizi | $20 |
| Ucb | Meals · 2025-06-13 | Bimzelx | $25 |
| Incyte | Meals · 2025-06-13 | Opzelura | $24 |
| Lilly USA | Meals · 2025-06-11 | Ebglyss | $30 |
| Pfizer | Meals · 2025-06-06 | Cibinqo | $7 |
| Pfizer | Meals · 2025-05-30 | Cibinqo | $14 |
| Ucb | Meals · 2025-05-29 | Bimzelx | $19 |
| Genzyme | Meals · 2025-05-28 | Dupixent | $21 |
| Pfizer | Meals · 2025-05-24 | Cibinqo | $15 |
| Abbvie | Meals · 2025-05-21 | Skyrizi | $19 |
| Abbvie | Meals · 2025-05-17 | Rinvoq | $7 |
| Abbvie | Meals · 2025-05-17 | Rinvoq | $7 |
| Abbvie | Meals · 2025-05-17 | Rinvoq | $4 |
| Galderma Laboratories L.P. | Meals · 2025-05-15 | Nemluvio | $17 |
| Ucb | Meals · 2025-05-09 | Bimzelx | $14 |
| Ucb | Meals · 2025-05-01 | Bimzelx | $2 |
| Ucb | Meals · 2025-05-01 | Bimzelx | $5 |
| Pfizer | Meals · 2025-05-01 | Cibinqo | $14 |
| Abbvie | Meals · 2025-04-29 | Skyrizi | $19 |
| LEO Pharma | Meals · 2025-04-25 | Adbry | $24 |
| Lilly USA | Meals · 2025-04-17 | Taltz | $15 |
| Lilly USA | Meals · 2025-04-17 | Taltz | $3 |
| Regeneron Healthcare Solutions | Meals · 2025-04-16 | Dupixent | $24 |
| Regeneron Healthcare Solutions | Meals · 2025-04-09 | Libtayo | $38 |
| Abbvie | Meals · 2025-04-04 | Rinvoq | $12 |
| LEO Pharma | Meals · 2025-04-04 | Adbry | $20 |
| Ucb | Meals · 2025-03-28 | Bimzelx | $29 |
| MIMEDX Group | Meals · 2025-03-25 | None | $36 |
| Abbvie | Meals · 2025-03-21 | Rinvoq | $22 |
| Lilly USA | Meals · 2025-03-18 | Taltz | $24 |
| Ucb | Meals · 2025-03-13 | Bimzelx | $17 |
| Pfizer | Meals · 2025-03-07 | Cibinqo | $17 |
| Regeneron Healthcare Solutions | Meals · 2025-02-27 | Dupixent | $21 |
| Abbvie | Meals · 2025-02-26 | Skyrizi | $21 |
| Abbvie | Meals · 2025-02-21 | Skyrizi | $19 |
| Lilly USA | Meals · 2025-02-18 | Taltz | $27 |
| Pfizer | Meals · 2025-02-14 | Cibinqo | $10 |
| LEO Pharma | Meals · 2025-02-07 | Adbry | $24 |
| Genzyme | Meals · 2025-02-04 | Dupixent | $24 |
| Janssen Biotech | Meals · 2025-01-28 | Tremfya | $14 |
| Abbvie | Meals · 2025-01-22 | Skyrizi | $30 |
| Organon | Meals · 2025-01-17 | Vtama | $26 |
| Pfizer | Meals · 2025-01-16 | Cibinqo | $5 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-01-10 | Sotyktu | $19 |
| Abbvie | Meals · 2025-01-09 | Skyrizi | $23 |
See earlier years (2024, 2023, 2022, 2021)
2024: $1,379
| Abbvie | Skyrizi | $510 | 29 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $185 | 6 payments
|
| Lilly USA | Taltz | $179 | 8 payments
|
| Regeneron Healthcare Solutions | Dupixent | $110 | 5 payments
|
| Amgen | Otezla | $58 | 2 payments
|
| LEO Pharma | Adbry | $40 | 2 payments
|
| Ucb | Bimzelx | $36 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $31 | 2 payments
|
| Sun Pharmaceutical Industries | Absorica Ld | $27 | 1 payment
|
| Arcutis Biotherapeutics | Zoryve | $23 | 1 payment
|
| Incyte | Opzelura | $23 | 1 payment
|
| Genentech USA | Erivedge | $22 | 1 payment
|
| Verrica Pharmaceuticals | Ycanth | $22 | 1 payment
|
| Smith+Nephew | Grafix Pl | $21 | 1 payment
|
| Genzyme | Dupixent | $21 | 1 payment
|
| Biofrontera | Ameluz | $19 | 2 payments
|
| Janssen Biotech | Tremfya | $18 | 1 payment
|
| Dermavant Sciences | Vtama | $18 | 1 payment
|
| Pfizer | Cibinqo | $16 | 1 payment
|
2023: $1,614
| AbbVie | Skyrizi | $674 | 33 payments
|
| Amgen | Otezla | $239 | 8 payments
|
| Sun Pharmaceutical Industries | Winlevi | $135 | 7 payments
|
| Genzyme | Dupixent | $83 | 3 payments
|
| Novartis Pharmaceuticals | Xolair | $82 | 4 payments
|
| Regeneron Healthcare Solutions | Dupixent | $69 | 3 payments
|
| Incyte | Opzelura | $68 | 3 payments
|
| Ucb | Bimzelx | $50 | 3 payments
|
| Lilly USA | Taltz | $49 | 2 payments
|
| Fresenius Kabi USA | Idacio | $44 | 2 payments
|
| Pfizer | Eucrisa | $42 | 2 payments
|
| Kyowa Kirin | Poteligeo | $23 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $22 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $19 | 1 payment
|
| Dermavant Sciences | Vtama | $15 | 1 payment
|
2022: $1,026
| Abbvie | Skyrizi | $436 | 21 payments
|
| Novartis Pharmaceuticals | Cosentyx | $164 | 11 payments
|
| Janssen Biotech | Remicade | $122 | 7 payments
|
| Amgen | Otezla | $117 | 6 payments
|
| Regeneron Healthcare Solutions | Dupixent | $91 | 4 payments
|
| Lilly USA | Taltz | $31 | 1 payment
|
| Incyte | Opzelura | $18 | 1 payment
|
| Sun Pharmaceutical Industries | Winlevi | $17 | 1 payment
|
| LEO Pharma | Adbry | $16 | 1 payment
|
| Pfizer | Eucrisa | $13 | 1 payment
|
2021: $665
| AbbVie | Skyrizi | $281 | 20 payments
|
| Genzyme | Dupixent | $170 | 5 payments
|
| Janssen Biotech | Remicade | $73 | 4 payments
|
| Novartis Pharmaceuticals | Cosentyx | $45 | 3 payments
|
| Lilly USA | Taltz | $32 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $26 | 1 payment
|
| LEO Pharma | Finacea | $22 | 1 payment
|
| Sun Pharmaceutical Industries | Absorica Ld | $16 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 100.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1114399334
- Licence
- CA 52961
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 2725 Mendocino Ave, Santa Rosa, CA, 95403
- NPI first listed
- 2015-10-27
- NPI last updated
- 2017-04-28
This is when the NPI record was last certified, not a medical board exam.